Objectives: To review the evidence of the involvement of the Wnt signalling pathway in mood disorders and in the action of drugs used to treat these disorders. Methods: We performed a careful PubMed search using as keywords all possible terms relevant to the Wnt pathway and crossing them with each of four areas, i.e., developmental effects, behavioural effects, mood disorders, and drugs used in their treatment. Papers were selected on the basis of their content and their data used for discussion. Results: Neurodevelopmental and behavioural data point to the possibility of involvement of the Wnt pathway in the pathophysiology of mood disorders. Clinical and post-mortem data are not sufficient to corroborate a definite role for Wnt alterations in any mood disorder. Combining genetic and pharmacological data, we may state that glycogen synthase kinase is the key molecule in bipolar disorder, as it is connected with many other signalling pathways that were shown to be involved in mood disorders, while Wnt molecules in the hippocampus appear to be mainly involved in depressive disorders. Conclusions: Altered Wnt signalling may play a role in the pathophysiology of mood disorders, although not a central one. It is premature to draw conclusions regarding the possible usefulness of Wnt manipulations in the treatment of mood disorders. © 2012 Bentham Science Publishers.

The Wnt Pathway in Mood Disorders / Sani, Gabriele; Napoletano, Flavia; Forte, Alberto; Kotzalidis, Giorgio; Panaccione, Isabella; G. M., Porfiri; Simonetti, Alessio; Matteo, Caloro; Girardi, Nicoletta; C. L., Telesforo; Serra, Giulia; Silvia, Romano; Giovanni, Manfredi; Valeria, Savoja; S. M., Tamorri; Koukopoulos, Alexia; Daniele, Serata; Rapinesi, Chiara; DEL CASALE, Antonio; Nicoletti, Ferdinando; Girardi, Paolo. - In: CURRENT NEUROPHARMACOLOGY. - ISSN 1570-159X. - STAMPA. - 10:3(2012), pp. 239-253. [10.2174/157015912803217279]

The Wnt Pathway in Mood Disorders

SANI, Gabriele;NAPOLETANO, FLAVIA;KOTZALIDIS, GIORGIO;PANACCIONE, ISABELLA;SIMONETTI, ALESSIO;GIRARDI, NICOLETTA;SERRA, GIULIA;KOUKOPOULOS, ALEXIA;RAPINESI, CHIARA;DEL CASALE, ANTONIO;NICOLETTI, Ferdinando;GIRARDI, Paolo
2012

Abstract

Objectives: To review the evidence of the involvement of the Wnt signalling pathway in mood disorders and in the action of drugs used to treat these disorders. Methods: We performed a careful PubMed search using as keywords all possible terms relevant to the Wnt pathway and crossing them with each of four areas, i.e., developmental effects, behavioural effects, mood disorders, and drugs used in their treatment. Papers were selected on the basis of their content and their data used for discussion. Results: Neurodevelopmental and behavioural data point to the possibility of involvement of the Wnt pathway in the pathophysiology of mood disorders. Clinical and post-mortem data are not sufficient to corroborate a definite role for Wnt alterations in any mood disorder. Combining genetic and pharmacological data, we may state that glycogen synthase kinase is the key molecule in bipolar disorder, as it is connected with many other signalling pathways that were shown to be involved in mood disorders, while Wnt molecules in the hippocampus appear to be mainly involved in depressive disorders. Conclusions: Altered Wnt signalling may play a role in the pathophysiology of mood disorders, although not a central one. It is premature to draw conclusions regarding the possible usefulness of Wnt manipulations in the treatment of mood disorders. © 2012 Bentham Science Publishers.
2012
antidepressant drugs; antipsychotic drugs; bipolar disorder; major depression; mood disorders; mood stabilising agents; wingless (wnt) signalling
01 Pubblicazione su rivista::01a Articolo in rivista
The Wnt Pathway in Mood Disorders / Sani, Gabriele; Napoletano, Flavia; Forte, Alberto; Kotzalidis, Giorgio; Panaccione, Isabella; G. M., Porfiri; Simonetti, Alessio; Matteo, Caloro; Girardi, Nicoletta; C. L., Telesforo; Serra, Giulia; Silvia, Romano; Giovanni, Manfredi; Valeria, Savoja; S. M., Tamorri; Koukopoulos, Alexia; Daniele, Serata; Rapinesi, Chiara; DEL CASALE, Antonio; Nicoletti, Ferdinando; Girardi, Paolo. - In: CURRENT NEUROPHARMACOLOGY. - ISSN 1570-159X. - STAMPA. - 10:3(2012), pp. 239-253. [10.2174/157015912803217279]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/495410
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 39
social impact